Key Highlights

  • Schrodinger shares closed up approximately 12.34 percent at $19.85, up $2.18 from the prior close of $17.67, hitting fresh highs during the session.
  • The rally builds on last week's second-quarter report, in which the company posted a surprise profit of $0.08 per share versus a consensus loss estimate.
  • Revenue of $58.9 million topped expectations of $47.2 million, alongside the launch of the company's Bunsen AI co-scientist platform.
  • BMO Capital reiterated a Buy rating with a $24 price target, flagging the stock as meaningfully undervalued.

Shares Surge on Return to Profitability

Schrodinger shares closed up about 12.34 percent at $19.85, hitting fresh highs during the session as investors continued to reward the company's return to quarterly profitability. The rally builds on last week's second-quarter report, in which the company posted a surprise profit of $0.08 per share versus a consensus loss estimate of $0.41, with Revenue of $58.9 million topping expectations of $47.2 million.

Schrodinger (NASDAQ:SDGR) is a New York based technology-enabled life sciences company that has developed a physics-based computational platform to accelerate the discovery of novel molecules for Drug Development and materials science applications, operating through its Software and Drug Discovery segments.

Bunsen Platform and Bristol Myers Squibb Deal Expand Growth Narrative

The report also included the launch of the company's Bunsen AI co-scientist platform, alongside a broadened deployment agreement with Bristol Myers Squibb, developments that have reinforced investor optimism around the company's computational drug discovery capabilities. These initiatives position Schrodinger to expand its software licensing revenue while continuing to advance its internal drug discovery pipeline.

Analyst Upgrade Adds Fuel to the Rally

BMO Capital reiterated a Buy rating with a $24 price target, flagging the stock as meaningfully undervalued on both GF Value and price-to-sales metrics, adding further momentum to the move. The advance stands out against a broader software sector that has largely lagged amid a semiconductor-led technology selloff and rising Treasury yields pressuring the wider market.

Where Things Stand

Schrodinger shares closed up about 12.34 percent at $19.85, hitting fresh highs after the company's return to quarterly profitability and an expanded AI drug-discovery partnership. These are the verified facts as reported. Whether the rally continues may depend on sustained profitability and continued adoption of the company's computational drug discovery platform.